Molecular targets and targeted therapies for malignant mesothelioma.
about
A binding domain on mesothelin for CA125/MUC16Cancer models in Caenorhabditis elegans.Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysisPhase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1P.Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activityNutritional stress and arginine auxotrophy confer high sensitivity to chloroquine toxicity in mesothelioma cells.
P2860
Molecular targets and targeted therapies for malignant mesothelioma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular targets and targeted therapies for malignant mesothelioma.
@en
Molecular targets and targeted therapies for malignant mesothelioma.
@nl
type
label
Molecular targets and targeted therapies for malignant mesothelioma.
@en
Molecular targets and targeted therapies for malignant mesothelioma.
@nl
prefLabel
Molecular targets and targeted therapies for malignant mesothelioma.
@en
Molecular targets and targeted therapies for malignant mesothelioma.
@nl
P2093
P1476
Molecular targets and targeted therapies for malignant mesothelioma
@en
P2093
Andrea Modesti
Antonio Procopio
Roberto Bei
P304
P356
10.2174/092986708783955446
P577
2008-01-01T00:00:00Z